Literature DB >> 11085581

Macaque blood-derived antigen-presenting cells elicit SIV-specific immune responses.

Y Zhu1, K Koo, J D Bradshaw, W F Sutton, L R Kuller, R Bucala, D Anderson, S P Mossman, F Villinger, N L Haigwood.   

Abstract

Natural blood-borne antigen-presenting cells (APCs) were tested for their ability to augment antigen presentation for SIV vaccines. Fibrocytes and monocyte-derived dendritic cells (DCs) were isolated from multiple Macaca fascicularis. Macaque fibrocytes displayed the characteristic cellular morphology and stained positive for CD34 and collagen, as observed in human and murine fibrocytes. Macaque DCs were generated from monocytes by culturing in granulocyte-macrophage colony stimulating factor and interleukin-4 (IL-4). Two days after maturation, cells were enriched for the DC marker CD83. Fibrocytes and DCs were each transfected with green fluorescence protein expression plasmids or DNA expression vectors encoding all of the SIVmne structural and regulatory genes. Autologous DCs were re-infused into macaques subcutaneously (sc) following transfection; mixing with recombinant SIV antigens or inactivated whole SIV in vitro; or mock-treatment. Autologous monocyte-derived DCs pulsed with whole inactivated SIV were re-infused and elicited cellular and/or humoral responses in vivo in eight of ten vaccinated macaques.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11085581     DOI: 10.1034/j.1600-0684.2000.290312.x

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  6 in total

Review 1.  Understanding and exploiting dendritic cells in human immunodeficiency virus infection using the nonhuman primate model.

Authors:  Simon M Barratt-Boyes; Kevin N Brown; Nada Melhem; Adam C Soloff; Sherrianne M Gleason
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

2.  Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge.

Authors:  N A Doria-Rose; C Ohlen; P Polacino; C C Pierce; M T Hensel; L Kuller; T Mulvania; D Anderson; P D Greenberg; S-L Hu; N L Haigwood
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

3.  Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies.

Authors:  Nancy L Haigwood; David C Montefiori; William F Sutton; Janela McClure; Andrew J Watson; Gerald Voss; Vanessa M Hirsch; Barbra A Richardson; Norman L Letvin; Shiu-Lok Hu; Philip R Johnson
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 4.  Dendritic Cells in HIV/SIV Prophylactic and Therapeutic Vaccination.

Authors:  Eun-Ju Ko; Marjorie Robert-Guroff
Journal:  Viruses       Date:  2019-12-24       Impact factor: 5.048

5.  Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation.

Authors:  Divya Sagar; Anne Lamontagne; Catherine A Foss; Zafar K Khan; Martin G Pomper; Pooja Jain
Journal:  J Neuroinflammation       Date:  2012-10-26       Impact factor: 8.322

6.  Kunjin replicon-based simian immunodeficiency virus gag vaccines.

Authors:  Itaru Anraku; Vladislav V Mokhonov; Paweena Rattanasena; Ekaterina I Mokhonova; Jason Leung; Gorben Pijlman; Andrea Cara; Wayne A Schroder; Alexander A Khromykh; Andreas Suhrbier
Journal:  Vaccine       Date:  2008-04-21       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.